Abstract
This is an updated review of the recently described entity, placental mesenchymal
dysplasia, which has been shown to have recognizable antenatal characteristics, distinctive
gross and microscopic pathologic findings, associated fetal and neonatal morbidity
and mortality, and unique pathogenic mechanisms. Recent understanding of the frequently
associated genotype, androgenetic biparental mosaicism, is reviewed and the spectrum
of changes discussed.
Keywords
Placental mesenchymal dysplasia - Androgenetic biparental mosaicism - Neonatal morbidity